Alternatives to Saama

Delineate assembles clinical pharmacology evidence into MBMA databases and models for dose optimization and go/no-go decisions.

Owkin's K Pro is an autonomous AI scientist for drug discovery and clinical trial decisions, built on multimodal patient data

Innovaccer runs healthcare AI agents over one governed data layer for population health, revenue cycle, and utilization management.

Clinical intelligence software for health plans that connects utilization management, payment integrity, appeals, care management, quality and claims

BenevolentAI applies a decade-built biomedical knowledge graph to drug target discovery and repurposing for biopharma R&D teams.

Kim by Oculi Medical reads your lab PDFs and wearable data to deliver daily personalized health guidance.

FHIR-native healthcare data API that pulls complete U.S. patient records from HIEs, ADT feeds, pharmacies, labs, and EHRs into one consolidated query.

Harbor is an AI-native EDC platform that turns your protocol PDF into a clinical trial database build in minutes.

Clinician-centered clinical trial matching that notifies your patients when a local, medically relevant study exists.

PicnicAI turns patient health records into clinical research data and real-world evidence.

BioStack Platforms supplies structured clinical datasets and RL environments for healthcare AI teams.

Frekils is AI agents for real-world evidence studies — cohorts, SAPs and publication-ready statistics on your own clinical data.

Enterprise clinical AI platform unifying radiology, cardiology, neurovascular and vascular care on one system.

Clinical-stage techbio company pairing automated wet labs with AI models to discover and develop drugs.

Clinical imaging AI that gives radiologists an assistive second read on chest X-ray, CT brain, and CT chest studies.

Clinical-stage biotech designing highly selective small-molecule drugs for oncology, immunology, and metabolic disease.

Generative AI drug discovery suite spanning target ID, molecule design, biologics and clinical trial prediction.

Oncology real-world evidence built from point-of-care patient data, with AI-powered analysis layered on top.

BEKhealth reads structured and unstructured EHR data to match patients to trial protocols and to generate research-ready real-world data.

FDA-cleared AI for cancer pathology on H&E slides, plus the Virchow and PRISM foundation models licensed to biopharma and researchers.

Employer and health-plan mental health benefit combining therapy, coaching, medication management, and self-guided care under one AI-assisted platform.

Radiology AI orchestration: one PACS/RIS integration, 300+ third-party AI apps, validated on your own data before you deploy.

Tempus pairs tumor DNA/RNA sequencing with AI precision oncology analytics to surface treatment and trial matches

Causal AI drug discovery that pairs 20+ petabytes of cellular data with human genetics to find real disease targets

Docus is an AI layer for diagnostic labs that turns raw lab results into doctor-ready clinical reports and plain-language patient explanations.

AI clinical intelligence for inpatient EHR workflows

PathAI's AISight Dx brings FDA-cleared digital pathology and AI biomarker algorithms to labs and biopharma trials.

Recursion runs AI drug discovery as a lab-in-the-loop engine — automated cellular imaging at scale feeding generative chemistry and a clinical pipeline.

Enterprise scientific intelligence platform whose Luma Agent plans, runs and documents R&D data analysis under human approval

Recursion's AI drug discovery platform pairing 2M weekly wet-lab experiments with a 50+ PB proprietary dataset, now incorporating Exscientia.